Recommended Global Neuroscience Webinars & Conferences
We welcome you and appreciate your participation at the 34th World Congress on Neurology, which is going to be held during July 18-19, 2022 Vienna, Austria and will be organized around the theme "Advances in Neurology and Neuroscience and Emerging Challenges".
Our Neurology 2022 also discusses current development in the research area of neurology as other neurological events and would promises to be the finest platform for anybody to learn from the latest trends in research and development in neuroscience.
What’s new and different about our Neurology Conferences?
We strive to arrange this year to satisfy the highest conference quality requirements with real input from our last number of neurological conferences.
Keynote lectures | Speaker sessions | Young Researchers Forum | Poster Competition | Video Presentations | Exhibitors Presentations and many more…
A science program appealing. All participants participating throughout the full day can offer their points of view/presentations and at the conclusion, without hesitation, voice their questions about the presentation.
The main objective is to collect more people from different strands of relevant disciplines of neuroscience to make this multidisciplinary.
Certification for all the attendees.
Interact with the world’s leading experts- Networking.
The relevant Journals will publish all approved abstracts in this Congress. A Cross Ref DOI is supplied for each abstract.
Speaker and abstract sites established under your name in Google, which bring international recognition for your profile and research.
Finally, we want to catalyze novel therapeutic concepts that benefit the range of neurological and brain diseases.
Who can join??
Neurology studies are carried out by neurologists, Neurosurgeons, Psychiatrists, Neurobiologists, Neuroimmunologists as well as members of neurology organizations, pharmaceutical companies, Neuropathic Associations & Foundations, CNS Drug Industries, Neuroscience Associations, Academic professors and students.
Neuroscience researchers Directors, neurologists, neurochirurgists, psychiatrists, department heads, Professors and Academy students.
• 50 per cent academia
• 40% of industry
• additionally 10%
About 500 people throughout the world
- Dalhousie University
- Leiden University- Neither land
- Temple University USA
- University Oklahoma
- Boston Coll USA
- Florida International University
- University California – Davis
- University Sheffield
- University Manchester
- University of Nottingham
- Cardiff University
- University of Toronto – Canada
Hospitals Associated with Neuroscience Research
All around the globe there are 6000 hospitals working on Neurology
Some of them among them are:
- Johns Hopkins Hospital
- World Brain Centre Hospital
- Duke University Hospital
- Edward Hospital
- Munson Medical Centre
Session & Tracks
Track 1: Neurology Insights and Innovations
The neurology research is concerned with the treatment and diagnosis of the peripheral and central nervous system of all disease types. Neurological diseases are shown to be one of the largest dangers to public health. So, here we are to mark its significance by spreading the awareness among the people and also to encourage the brilliant ideas of our researchers globally. Overview of subtopics included in this session
- Current advances in Neurology research
- Neurological disorders
- Brain Disorders
- Spinal Disorders
- Psychiatric disorders
- Pediatric Neurology
- Cognitive and Behavioral Neurology
Track 2: CNS and Brain disorders
The illnesses affecting the brain and central nervousness are CNS and brain disorders. According to the studies, about 164m Europeans face brain-related diseases, such as Alzheimer's disease (Alzheimer's disease, Parkinson's disease, epilepsy).
It covers the diagnosis, treatment, prevention/curation of illnesses or brain dysfunction, peripheral nerves, the spinal cord and neural vessels.
- Central nervous system disorders
- Autonomic nervous system disorders
- Alzheimer’s Disease and Dementia
- Parkinson’s and Huntington’s Disease
- Anxiety and Depression
- Autism Spectrum Disorder
- Bipolar Disorder
Track 3: Neurodegenerative Disorders
The gradual loss of neuron structure or function that leads to diseases such as Alzheimer's disease, Parkinson's disease, etc. called neurosensitive or neural death. In the United States, over 60,000 Parkinson's disease cases are identified annually. The following areas of debate are highlighted in this session: Motor neuron and ataxia, Alzheimer's, diagnostic mechanism, new insights and therapeutics for Parkinson's disease and lateral sclerosis amyotrophic.
- Alzheimer’s Disease and Dementia
- Novel Insights of Parkinson’s disease
- Amyotrophic lateral sclerosis (ALS)
- Huntington’s disease
Track 4: Clinical Neurology and Neurosurgery
The discussion on clinical neuroscience is marvelous because it focus on the underlying processes of brain and central nervous system illnesses and disorders, and aims at developing new techniques of diagnosing such problems, which lead to the creation of new medicines. Neural disturbances impact about 1 billion individuals worldwide, represent 12 per cent of the illness burden internationally and cause 14 per cent of global mortality, according to estimates by the World Health Organization. The conference will focus on Post-operative neuralgia, brain tumor and metastasis based on illness prevalence,
Oncological neurochirurgists, spine operations Neuroanesthesia, operations and vascular dysfunctions and operations. It is therefore necessary to improve our understanding of current procedures of Neurosurgery and different elements
- Clinical aspects of neurology
- Investigating biomarkers
- Clinical Trials
- Spine surgery
Neuroscientists combine the immune system and the neurological system, which is a branch of neuroscience. The immune system provides defense measures and inefficiency in infections leads to the same. In underdeveloped nations, the situation has been considerably worse and in Australia it has been a major health concern. Approximately 350,000 to 500,000 individuals in the USA have MS.
Our conference on Neurology provides a platform for assembling our brains and thrashing out the causes of multiple sclerosis and autoimmune neuropathies, Neuro-immune illnesses, neuromicrobial disorders, neuroinflammatory diseases, Neuroimmuno genetics.
- Multiple sclerosis
- Neuroinfections disease
The study of nervous system tissue diseases is dealt with in neuropathology. In addition, the neuropathologist generally examines muscle & peripheral nerve samples as well as the central nervous system tissue. Nervous system cells and the arrangement of these cells into functional circuits, which process information and mediate behavior, are studied in Neurobiology.
Track 7: Pediatrics Neurology
Pediatric in most young people or adolescent’s neurology occurs. In around 6 in 100,000 young people, Neurology impacts them. Children's neurology is of 3 basic types; of which two is chemical neurology involves blocking venous results in the absence of blood flow and damage. The term is chemical neurology (AIS) is used when the corridor is closed. The phrase cerebral Sino venous thrombosis is used when a vein is blocked (CSVT). In the third form the venous crack, rather than being plugged, is hemorrhagic neurology (HS). More frequently than on one side of the body, the most common symptoms and neurological side effects include the abrupt emergence of the failure or mortality of the face, arm or leg.
- Movement disorders (Cerebral paresis)
- Muscle diseases
- Lysosomal storage disease
- Development disorders
- Brain malformations
Different conferences on neurology take place worldwide to increase understanding about neuroscience and strengthen it. Our 29th World Congress on Neurology and Therapy, held in London in February 2020, covers all relevant fields of research focusing on new cell and molecular therapy and diagnostics. The diagnostic method and the development of medicines in the field of neurology are steadily increasing.
The meeting of technologists is encouraged to discuss neurological diseases and treatment to speed up discoveries in new diagnostic therapies; Injuries and repairs of nerves, Headache and sleep disturbances, New treatments for neurological diseases and neurogenesis have developed.
- Stem cells and treatment
- Nerve injury and repair
- Clinical Case reports
- Cell and gene based approaches
- Neurotransmitter release and cell repair
Track 9: Neuropharmacology and Neuro genetics
Our 2020 Neurology intends to train new researchers on Neuroimmunopharmacology and pharmacological interference with the mechanism of neuronal disorders. Genes impact the wiring and functioning of the brain, which is the competence of all our trips. Ultimately, it is only the genes which produce a certain sort of protein which is useful and dangerous and which represents the need for study in this specific area. An important part of human illnesses and ailments is accounted for by 6000 or more developing genetic disorders. The following pathways are intended to clarify concepts relating to Huntington's disease (HD) and associated genetic diseases, genetic engineering, for the purpose of overcoming neurological difficulties. Recent Drug development
- Neuro genetics
- Gene mutation and disease
- Genetic engineering and Gene sequencing
- Biochemical genetics
What strikes you is that technology, such as Brain Engineering and neural engineering, may be utilized to analyses, repair, replace, improve or otherwise utilize the neurological systems' characteristics. Current Neuroengineering research includes: imagery and neural networking, neural regeneration Bio-molecular therapy, neurorobotics, neural biology networking, neuro hydrodynamics and clinical treatment, engineering strategy for repair. Engineering, Clinical neuroscience of computational, biological neuron modelling, network behavior and improved therapy. The progress made in the brain computer and deep brain stimulation investigations is also being shed light on.
- Neural engineering
- Current research in neuroimaging
- Biomarkers in Neuroimaging
- Neural networking
- Bimolecular therapies in Neural regeneration
Track 11: Psychiatry, Psychology and Mental Health
It focuses on the combined research and treatment of people with psychiatry and neurology. Neuropsychiatry supports the neuroscience area and is used to understand mental and neurological illnesses better and to study therapy and care of neurologically affected individuals in particular Psychology is the field of behavior, mind, consciousness and unconsciousness of people. Psychologists often participate in research, teaching, consultation, and even legal proceedings. There are just a few psychologists who are working on how human beings interact to each other and the computer and work on improving the relationship. They focus on the health and well-be.
- Neuropsychiatric disorders
- Adolescent psychiatry
- Child Psychology
- Clinical psychology
- Cognitive psychology
- Psychological Disorders
Track 12: Pharmaceutical Research in CNS/Neurology
The advances in technology and our understanding of the nervous system led to the creation of medication products and treatments in the two major areas of molecular and behavior that are beyond our imagination. New pharmacological methods for neural diseases treatment, cell signal drug development and synaptic spasticity and recent advances in neuropharmacology therapy and pharmaceutical development in this specific area are now being addressed.
- Clinical Neuropharmacology
- Molecular Neuropharmacology
- Biochemical Neuropharmacology
- Behavioral Neuropharmacology
- Neuro-Pharmacotherapy and Pharmacotherapeutics
- Neuropeptides and Neurohormones
- Neurotransmitters and signaling molecules
Track 13: Neurological Nursing
Nursing is a highly difficult subject to evaluate and treat various neurological diseases in which nurses offer care to the patient. A neuroscience nurse treats patients with trauma, skull rot, seizures, tumors, headaches, infections, aneurysms, as well as a range of other neural complications, brain and nervous system problems.
- Nursing practices
- Pediatrics Nursing
- Neurosurgical Nursing
- Critical Care Nursing
- Clinical Nursing
- Healthcare Nursing
- Nursing Management
Track 14: Neurodegenerative Diseases and Stress
A variety of neurodegenerative illness, including Alzheimer's (DA), Perkin’s (PD) and amyotrophic lateral sclerosis, was affected by oxidative stress (ALS). These illnesses are characterized by severe lipid, protein, and DNA oxidative damage.
In several neurodegenerative illnesses anxiety is a frequent symptom with prevalence estimates varying from 5% to 21% for anxiety disorder and 8% to 71% for symptoms of anxiety (see review in Seigneurial et al. 2020).
Aβ, α-syncuclein and SOD were discovered by Genetics as having a key function in AD, PD and ALS. These proteins make up the majority of the deposits associated with these illnesses. The next ROS production showed that all of these proteins interact with redox active metal ions.
Factors that might enhance the risk of oxidative stress of a person include obesity.
- Fat, sugar and processed foods high diets.
- Radiation exposures.
- Cigarettes for smoking or other goods for tobacco.
- Consumption of alcohol.
- Some medicines.
- Pesticides and industrial chemicals exposure
Track 15: Alzheimer and Parkinson Diseases
Alois Alzheimer characterized the Alzheimer's later dementia (AD). Parkinson's "shaking paralysis" is used to diagnose PD, when a person displays two or more of the following signs: slower movement, muscular stiffness and tremor. PD is diagnosed (at rest)
Disease of Alzheimer's involves two major protein clumps: tau and beta amyloid. Beta amyloid aggregates are referred to as plaques and tau clumps are referred to as tangles. The illness of Parkinson contains Lowy organisms, which govern movement in critical regions of the brain; Lowy organisms have the alpha-syncline protein.
When patients approach phase 5 - the ultimate stage of Parkinson's disease - the back, neck and hips suffer from serious postural problems. You need a wheelchair and you can bed. Patients commonly have non-motor symptoms near the conclusion of Parkinson's disease.
Track 16: Neurological Disorders and Stroke
Stroke: If the blood circulation to the brain fails, a stroke, or "brain attack," happens. Brain cells can perish as a result of reduced blood circulation and an oxygen shortage. There are two major kinds of stroke : blocking blood flow and bleeding into the brain. The most prevalent cause and responsible for around 80 per cent of stroke is the blocking of a brain or neck blood artery called an ischemic stroke.
Signs of neurological problems: Neurons perish in this brain area without the oxygen provided by blood flow. Depending on the brain region affected, this neuronal death can produce many various symptoms, including headache, muscular weakness or paralyses, speech disorders, sensory difficulties, memory loss and disorientation.
Disorders of the CNS:
Track 17: Ophthalmology and Visual Neuroscience
Ophthalmology: A neurophthalmologist can identify and treat neurological and systemic illnesses that influence your eyesight. Tests may include electro-radiography, tomography of optical coherence and multi-focal EGRs.
Visual Neuroscience: Visual neuroscience is a sector of neuroscience that focuses on the human body's visual system, largely situated in the visual cortex of the brain. Visual neuroscience aims primarily at understanding how brain activity leads in both visual and behaviors.
Track 18: Neuropharmacology and Neurochemistry
The research on how medicines impact cell activity in the nervous system and the neural system through which they affect the behavior is conducted in neurochemistry and neuropharmacology. Neuropharmacology has two primary branches: compartmental and molecular.
A medication that interacts with neurons in the brain to influence emotion, sensation, behavior and thoughts is a study of neuropharmacology. Some (but not all) of these changes are caused by drug-induced changes in brain chemical transmitter activity (brain neurochemistry).
Molecular neuroscience in fundamental as well as clinical research is of considerable interest. Increasingly fresh results are communicated at an ever-growing rate on issues such as neuropeptides, nerve hormones and neuromodulators.
With the evolution of molecular biology, designer medicines are adapted to impact behavior, cognition and memory building. At the moment, three major areas are focused:
- Improved awareness and mood
- Improved storage and recovery of memory
- Memory formation blocking or hindering.
Track 19: Brain Injury and Behavioral Neuroscience
Injuries of the Brain might affect behavior, regulate impulses and self-awareness significantly. These consequences are caused by damage to emotions and impulses regulating brain sectors, including wrath, impulsive conduct, self-centeredness, a deprived consciousness and even violence.
This includes motivation, perception, attention, learning and memory, and motor performance and provides insights into how the brain, behavior and environment interact in a complex way. In order to explore neuronal cognition in animal models, researchers employ several types of behavioral paradigms.
- Magnetic Stimulation Transcranial
- Injection of synthetic ligand
- Psychopharmacological manipulations
- Ontogenetic inhibition
- Magnetic Stimulation Transcranial
Neuroimmunology is an area that combines neuroscience, nervous system study with immunology, immune system analysis. In the development, homeostasis and injury response, Neuroimmunologists try to better understand the interconnections of both complex systems.
The areas of neurology, Neuro-immunology, and immunology have their beginnings as a distinct study. Another research area that has been expanding rapidly has been developed with the aim of understanding pathology mechanisms of inflammatory components from neurological disturbances by early brain studies by Golgi and Cajal, detailed Charcot clinical and neuropathology studies and a seminal paper by Thompson regarding the central nervous system graft acceptance.
COVID-19 Effect on Neuro System:
- Two diseases with a recently proven connection include neurological disorders and the coronavirus 2019 (COVID-19).
- Interesting findings indicated that infection with COBID-19 may affect, but also plays an important part in the development of future diseases as long-term repercussions, the entire range of exhibited neurological conditions.
- In this research the sensitivity of COVID-19 infection and development among neurological diseases to SARS-CoV-2 was assessed.
Track 21: Psychology, Cell & Molecular Biology
A cell is an externally bound mass of a cytoplasm by a membrane of the cells. Cells are usually tiny in size and form the smallest structural elements of living stuff. Most cells carry out a wide array of functions using one or more nuclei.
CELLULAR AND MOLECULAR BIOLOGY: This discipline examines the structure, function, intracellular processes and cell development in an interdisciplinary approach. Studies entail a study of the specific molecular knowledge of life and cellular activities.
Notable molecular biologists edit
Our organising team is preparing an interesting and educational conference programme including plenary talks, symposiums, and seminars on a range of themes, poster presentations and different programmes. In London, UK, we are looking forward to meet.
For more details please visit- https://neurology.global-summit.com/
Neurology Market Scope
34th World Neurology Congress is a unique forum for world-famous researchers, public health practitioners, scientists, academics, industry researchers, academics to share ideas in the field of research in neurology to encourage new therapeutic insights that will benefit the entire spectrum of Neurology.
Why this Conference happening?
The burden of neurological diseases has grown significantly during the past 25 years. The major cause of mortality and disability worldwide today are neurological diseases. Neurological diseases were the most prevalent
Everyone's Eve (about 1,500 million)
Migration (about 1,000 million)
Overuse of medication (about 60 million)
Disease and Dementia of Alzheimer (about 46 million)
Between 1990 and 2015, there was 36.7% rise in fatalities due to neurological diseases, and 7.4% increase in DALYs. The rates of Parkinson's disease have been rising by 100,000 individuals (by 15.7%), Alzheimer's (2.4%), motor neurone (3.1%), and brain and nervous system malignancies tumours (8.9 per cent). Higher rates of neurological diseases in rural areas demand for urgently needed measures in India for 6–8 million individuals with epilepsy and for a high rate of stroke mortality (27–42 per cent).
Approximately 26,350 million USD were estimated in 2016 for the world neuroscience market and it is projected at about 34,800 million USD in 2024. Between 2017 and 2024, the world neuroscience market expects to show a CAGR of around 3.5%.
- Neurology Insights and Innovations
- CNS and Brain disorders
- Neurodegenerative Disorders
- Clinical Neurology and Neurosurgery
- Neuroinfections and Neuroimmunology
- Neuropathology and Applied Neurobiology
- Neurotherapeutics, Diagnostics and Case Studies
- Neuropharmacology and Neurogenetics
- Neurophysiology, Neuroimaging and Radiology
- Psychiatry, Psychology and Mental Health
- Pharmaceuticals in CNS/Neurology
- Neurological Nursing
A Unique Opportunity for Advertisers and Sponsors at this International event:
Brain & Brain research foundations throughout the world
• Neuropathy Association
• Association of Alzheimer
• U.S. Neurology Academy
• European Societies of Neurology
• World Neurological Federation
• Sociedad de Neurología de España
• Foundation of Hilarescere in Italy
• MS company in Italy Italian
• Southern Clinical Society of Neurology
• European Neuroradiological Society ESNR
• Society Vision of Science
Past Conference Report
Webinar of February 22–23, 2021, the 30th World Neurology Congress. We successfully held the event at the site of the conference with the cooperation and involvement of the members of the organisation.
First of all we should thank you for believing us in Neurology 2021, a worldwide forum to debate different key areas of neurology and neuroscience.
There are endless reasons to thank you for the excellent conference on Neurology 2021. Without your continuing support and belief in our company which mutually reached new heights in neurology and neuroscience in 2021, we would not have been able to do so.
The conference was distinguished by the participation of young and intelligent academics, business people and outstanding student groups from over 10 nations, who pursued the event successfully.
The symposium on "New insights into the neurological effects of COVID-19" was held. The event established a strong relationship with the scientific community of future neurological techniques. The information exchanged in idea and application will also encourage organisational cooperation with a view to encouraging scientific acceleration.
During the conference the following speakers were highlighted: Alex Kiselyov, Bionaut Laboratories, USA, Carla Elena Mezo-González, University of Nantes, France, Raffaele Pilla, St John, and God Hospital - Fatebenefratelli, Italy. The conference was organised through several Scientific Sessions and plenary lectures. The lecture was attended by peerless speakers, renowned researchers and participant delegates who, in their magnificent presentations at the 2021 Podium of Neurology, shone the croWds with their enviable research expertise and different attractive subjects linked to the area of neurology.
The LLC Ltd Congress Series extends its deepest thanks to the members, chairman and co-chairs of the Organizing Committee, speakers, students, media partners and editorial board, members of the Neurological Disorders Journal and the International Journal and the Spin Journals.
We also have to thank numerous delegate specialists, representatives of companies and other notable individuals, who supported the conference through active forums of debate. Thank you so much to the members of the organisation.
We would like to invite you warmly as the continuation of Neurology 2021 to our next 34th World Congress on Neurology, planned for Vienna, Austria, on 18-19 July 2022.
With an active contribution and support, we look forward to your benign presence to make this event a success once again.
All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.
Abstracts will be provided with Digital Object Identifier by